Treatment | Silymarin | physical function | physiological function | lifespan | Transcriptome | Proteome | Metabolome | Target | Reference | blinded |
CID (PubChem) | 31553 | ChEMBL | | | | | locomotion on solid media | | | | heat stress resistance | | | | oxidative stress resistance | | | | mean lifespan | | | | | | | | | |
Concentration | Exposure time | Food | Growth medium | Special additives | C. elegans strain | Temperature | Change compared to control | Percentual change compared to control | p < 0.05 | notes | Change compared to control | Percentual change compared to control | p < 0.05 | notes | Change compared to control | Percentual change compared to control | p < 0.05 | notes | Change compared to control | Percentual change compared to control | p < 0.05 | notes | | | | | | |
10 µM | whole life; start: parental generation | OP50, UV-inactivated | NGM agar | | N2 (wild type) | 20°C | | | | | | | | | | | | | up | 4.55 | yes | | | | | | Filippopoulou K, Papaevgeniou N, Lefaki M, Paraskevopoulou A, Biedermann D, Křen V, Chondrogianni N (2017) 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radic Biol Med 103, 256-267. | |
50 µM | whole life; start: parental generation | OP50, UV-inactivated | NGM agar | | N2 (wild type) | 20°C | | | | | | | | | | | | | up | 13.64 | yes | | | | | | Filippopoulou K, Papaevgeniou N, Lefaki M, Paraskevopoulou A, Biedermann D, Křen V, Chondrogianni N (2017) 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radic Biol Med 103, 256-267. | |
25 µM | whole life; start: L4 | OP50 | NGM agar | | N2 (wild type) | 20°C | up | 44.85 | yes | A10; endpoint: spontaneous movement; no significant change in number of body bends at A5 | up | 23.59 | yes | A5: stressor: 35°C for 4 h; endpoint: survival | | | | | up | 10.08 | yes | | | | | | Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302. | |
50 µM | whole life; start: L4 | OP50 | NGM agar | | N2 (wild type) | 20°C | up | 82.47 | yes | A10; endpoint: spontaneous movement; significantly increased number of body bends at A5 (+29.47%) | up | 42.21 | yes | A5: stressor: 35°C for 4 h; endpoint: survival | | | | | up | 24.80 | yes | | | | | | Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302. | |
100 µM | whole life; start: L4 | OP50 | NGM agar | | N2 (wild type) | 20°C | down | -25.26 | yes | A10; endpoint: spontaneous movement; no significant change in number of body bends at A5 | down | -25.76 | yes | A5: stressor: 35°C for 4 h; endpoint: survival | | | | | down | -8.95 | yes | | | | | | Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302. | |
25 µM | whole life; start: L4 | OP50 | NGM agar | | CL4176 {smg-1(cc546); dvIs27 [myo-3p::A-Beta (1-42)::let-851 3'UTR) + rol-6(su1006)]} | 16°C | up | | yes | pre-exposed to 25°C for 18-20 h; endpoint: ratio of non-paralyzed and paralyzed worms | | | | | | | | | | | | | | | | | Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302. | |
50 µM | whole life; start: L4 | OP50 | NGM agar | | CL4176 {smg-1(cc546); dvIs27 [myo-3p::A-Beta (1-42)::let-851 3'UTR) + rol-6(su1006)]} | 16°C | up | | yes | pre-exposed to 25°C for 18-20 h; endpoint: ratio of non-paralyzed and paralyzed worms | | | | | up | | yes | pre-exposed to 25°C; stressor: 10 mM paraquat; endpoint: motility | | | | | | | | | Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14, 295-302. | |